MVAP Medical Supplies’ industry-leading EEG catalog and distribution network continues Brain Scientific’s promotion with NeuroCap™, which is easy to use, easy to set up, and comfortable.
Lakewood Ranch, Florida, December 15, 2022 (GLOBE NEWSWIRE) — Via Investor Wire — brain science (OTCQB:BRSF)a Florida-based applied science and technology company, today announced a new distribution agreement with MVAP Medical Supplies to facilitate sales into the rapidly growing but underserved pediatric EEG market. .
“For pediatric EEG, Brain Scientific’s revolutionary NeuroCapTMs This solution is a perfect fit for reducing EEG set-up time and providing ease and comfort for staff and patients,” said Eric Jensen, CEO of MVAP Medical Supplies. “As anyone who has tried to keep a child sitting still for an hour procedure knows, patient comfort and speed of application are paramount in the field of pediatrics. We have arrived.”
An industry leader in sleep, EEG, EMG, IOM, respiratory and patient care supplies, MVAP Medical Supplies helps Brain Scientific further expand its sales and distribution network into key growth markets. The rapidly emerging medical wearables space.
“NeuroCap is designed to be a game changer in the wearable space for neurodiagnostics,” said Hassan Kotob, CEO of Brain Scientific. We are pleased to offer MVAP medical supplies on our journey to becoming a leading medical wearables provider in .”
MVAP medical supplies signing fulcrum When D&D Medical, Both aim to extend the reach of Brain Scientific’s wearable products into key strategic markets.
About Brain Scientific
Brain Scientific Co., Ltd. (brain science.com) is an applied science and technology company with multiple patents and FDA cleared products. Brain Scientific is committed to developing next-generation solutions that advance the future of medical and OEM devices. Brain Scientific has his two product lines covering neurology and precision movement. NeuroCap™ and NeuroEEG™ are smart neurological diagnostic devices that simplify management, reduce scan times and reduce costs.of piezo motion The product line consists of ultra-efficient miniature precision motors that power the next generation of OEM devices. For more information on Brain Scientific’s corporate strategy, products, or investor relations, please visit: brain science.com.
Statements contained in this press release that are not statements of historical fact may constitute forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding the following: (ii) projections of earnings (including gains/losses), earnings per share (including gains/losses), capital expenditures, dividends, capital structure or other financial items; (iii) future financial performance of the company; (iv) the successful integration of Piezo Motion and Brain Scientific; (v) assumptions underlying or relating to the statements set forth in (i), (ii), (iii), or (iv) above; Such forward-looking statements are not intended to predict or guarantee actual results, performance, events or circumstances, and are not intended to represent our current expectations, plans, objectives, beliefs, expectations, estimates and It is based on assumptions and is subject to numerous risks, uncertainties and other effects, many of which are beyond the Company’s control. Actual results, timing of particular events or circumstances may differ materially from those set forth in forward-looking statements as a result of these risks and uncertainties. Factors that could influence or contribute to the inaccuracy of forward-looking statements or that could cause actual results to differ materially from those anticipated or desired include the Company’s may not raise additional funds. The enormous amount of time and resources associated with product development and the associated inadequate cash flow and resulting illiquidity. The inability of the company to expand its business. Important government regulations for the medical device and healthcare industry. lack of product diversification; volatility in the company’s raw material prices; Failure to implement the company’s business plan or strategy. Some of these and other factors are identified and explained in more detail in the company’s filings with the SEC. We do not undertake to update these forward-looking statements.
IBN (Investor Brand Network)
Los Angeles, California